Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM EDT

Register Free →

PENNSYLVANIA DEPARTMENT OF INSURANCE

PENNSYLVANIA DEPARTMENT OF INSURANCE is a federal contractor, registered under UEI P7XXRN1453P3 and CAGE code 5X7D7. It has been awarded $758,875,300 across 14 federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Department Of Health And Human Services.

Contact Information

Registration and classification details

Registration

UEI Code

P7XXRN1453P3

CAGE Code

5X7D7

Entity Structure

U.S. Government Entity

Established

N/A

Business Classifications

U.S State Government

NAICS Codes

926150Regulation, Licensing, and Inspection of Miscellaneous Commercial Sectors(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

The Pennsylvania Department of Insurance is a state government entity responsible for regulatory oversight and enforcement within the insurance sector. Its core capabilities center on policy administration, consumer protection, market conduct examinations, financial solvency monitoring, and licensin...

The Pennsylvania Department of Insurance is a state government entity responsible for regulatory oversight and enforcement within the insurance sector. Its core capabilities center on policy administration, consumer protection, market conduct examinations, financial solvency monitoring, and licensing of insurance providers. The organization applies state-specific statutes and federal compliance frameworks to ensure market integrity, enforce rate filings, and investigate fraudulent activity. Technical expertise includes risk assessment modeling, data analytics for fraud detection, regulatory reporting systems, and interagency coordination with state and federal financial regulators. Its specializations lie in insurer solvency oversight, producer licensing compliance, and consumer complaint resolution systems, leveraging state-level regulatory authority to maintain market stability. No award history is available to infer specific agency partnerships or intergovernmental collaboration patterns. As a state regulatory body, it does not contract externally for services but performs its statutory duties directly under Pennsylvania law. The primary NAICS code 926150—“Other Regulatory Functions”—reflects its role as a non-law enforcement public regulator, distinct from commercial contractors. In practice, this means the entity operates as a statutory watchdog for the insurance industry, conducting audits, issuing cease-and-desist orders, approving policy forms, and overseeing insurer reserves. Its market positioning is exclusively within the state government regulatory space, serving as the authoritative body for insurance oversight in Pennsylvania. The entity is structured as a state agency under government classification 2A, indicating it is a non-federal, state-level organization. It holds no federal certifications, operates solely within Pennsylvania, and functions as an arm of the Commonwealth’s executive branch. Its geographic presence is confined to Harrisburg, PA, where it administers state insurance laws and coordinates with the Pennsylvania General Assembly and federal agencies such as NAIC and NCOIL on regulatory alignment.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
- Unknown NAICS$758.9M100%
Awards by Agency Over Time
Awards by Place of Performance

Compete with PENNSYLVANIA DEPARTMENT OF INSURANCE

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for PENNSYLVANIA DEPARTMENT OF INSURANCE

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in PENNSYLVANIA DEPARTMENT OF INSURANCE's top NAICS codes and agencies

NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
The NIH Small Business Technology Transfer (STTR) grant, solicitation PA-27-102, provides early-stage funding to United States small business concerns (SBCs) to conduct research and development for commercial products that align with the NIH mission to enhance health and reduce illness. A mandatory requirement for this program is a formal collaboration between the SBC and a non-profit research institution. The program is structured in phases, with Phase I focusing on establishing technical merit and feasibility, and Phase II advancing the research toward commercialization. Eligible applicants include U.S.-owned for-profit organizations with 500 or fewer employees. The solicitation accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with the latter two options designed to accelerate the development timeline. Funding limits vary by the awarding NIH Institute or Center, with Phase I awards typically ranging from 400,000 to 700,000 dollars and Phase II awards reaching up to 3,000,000 dollars. Applications are evaluated through a peer review system based on scientific merit, commercial potential, and the quality of the commercialization plan. While clinical trials are generally optional, they are not accepted by specific components such as NIAID, NIAMS, NIDCR, NIDDK, NIMHD, NCATS, and ORIP. Applicants must maintain active registrations in the System for Award Management (SAM) and the SBA Company Registry. Required documentation includes SF424 forms and, for clinical trials, a two-page regulatory plan. Recipients must also adhere to strict cybersecurity incident reporting requirements, notifying HHS agencies within 48 hours of any discovery.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
Solicitation PA-27-100 is a grant opportunity provided by the NIH, CDC, and FDA to support United States small business concerns in conducting research and development for the creation of commercial products. The program is structured in phases, with Phase I focusing on establishing technical merit and feasibility, and Phase II advancing the research toward commercialization. Eligible applicants include for-profit entities located in the U.S. with no more than 500 employees. The funding opportunity accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, provided the proposed work aligns with the missions of the participating agencies. Funding limits vary by institute, with Phase I awards typically ranging from 400,000 to 700,000 dollars and Phase II awards reaching up to 3,000,000 dollars. Applications are evaluated through a peer review system based on scientific and technical merit, significance, and the suitability of the business environment. Key requirements include maintaining an active SAM.gov registration with a Unique Entity Identifier and adhering to strict cybersecurity incident reporting guidelines, which require notification of breaches within 48 hours. While clinical trials are generally optional, they require a specific regulatory plan and registration on ClinicalTrials.gov, though certain institutes and FDA components will not accept clinical trial proposals under this specific notice. The application deadline is April 6, 2027.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The SBIR/STTR Commercialization Readiness Pilot (CRP) Program, solicitation PAR-27-098, is a funding opportunity provided by the National Institutes of Health (NIH) to help United States-based small business concerns transition technology from late-stage development to full commercialization. This program is specifically available to recipients of prior or active NIH SBIR or STTR Phase II or Phase IIB Strategic Breakthrough awards. The CRP supports activities that bridge the gap to market, including late-stage research and development, independent replication of key studies, manufacturing scale-up, and technical assistance such as regulatory strategy, intellectual property planning, and market research. While significant outsourcing to contract research organizations is permitted, the small business must maintain a substantial role in the oversight and management of the project. Eligible projects may have a maximum performance period of three years, with budget ceilings varying by the participating NIH Institute or Center, ranging from 500,000 dollars to 2 million dollars, or following SBA guidelines for certain institutes. Applications are evaluated through the NIH peer review system based on scientific and technical merit, relevance to program priorities, and commercial potential. Key requirements for applicants include maintaining active SAM registration, providing a detailed regulatory plan, and submitting a CRP progress report. It is important to note that while clinical trials are generally optional, several specific NIH components, including the NHLBI, NIAID, and NIDDK, do not accept clinical trials under this specific funding opportunity. Additionally, funding cannot be used for patent or FDA filing fees or separate Technical and Business Assistance (TABA) funding.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 6 months
View Details